Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial von Dutton, Susan J, MSc, Ferry, David R, Prof, Blazeby, Jane M, Prof, Abbas, Haider, MRCP, Dahle-Smith, Asa, MBChB, Mansoor, Wasat, PhD, Thompson, Joyce, FRCP, Harrison, Mark, PhD, Chatterjee, Anirban, FRCR, Falk, Stephen, MD, Garcia-Alonso, Angel, MD, Fyfe, David W, MD, Hubner, Richard A, PhD, Gamble, Tina, Peachey, Lynnda, BSc, Davoudianfar, Mina, BA, Pearson, Sarah R, BSc, Julier, Patrick, MSc, Jankowski, Janusz, Prof, Kerr, Rachel, MD, Petty, Russell D, MRCP

Volltext

Gefitinib and EGFR Gene Copy Number Aberrations in Esophageal Cancer von Petty, Russell D, Dahle-Smith, Asa, Stevenson, David A J, Osborne, Aileen, Massie, Doreen, Clark, Caroline, Murray, Graeme I, Dutton, Susan J, Roberts, Corran, Chong, Irene Y, Mansoor, Wasat, Thompson, Joyce, Harrison, Mark, Chatterjee, Anirban, Falk, Stephen J, Elyan, Sean, Garcia-Alonso, Angel, Fyfe, David Walter, Wadsley, Jonathan, Chau, Ian, Ferry, David R, Miedzybrodzka, Zosia

Volltext

Cardiotoxicity and Chemotherapy-The Role of Precision Medicine von Viswanathan, Thyla, Lang, Chim C, Petty, Russell D, Baxter, Mark A

Volltext

Resistance to immune checkpoint inhibitors in advanced gastro-oesophageal cancers von Baxter, Mark A., Middleton, Fearghas, Cagney, Hannah P., Petty, Russell D.

Volltext

Cancer Treatment Helpline: a retrospective study of the NHS Tayside experience von Trip, Ilse, George, Sherie, Thomson, Micheal, Petty, Russell D, Baxter, Mark A

Volltext

Predicting Response to Treatment in Gastroesophageal Junction Adenocarcinomas: Combining Clinical, Imaging, and Molecular Biomarkers von Bain, Gillian H., Petty, Russell D.

Volltext

The impact of COVID-19 on systemic anticancer treatment delivery in Scotland von Baxter, Mark A., Murphy, John, Cameron, David, Jordan, Judith, Crearie, Christine, Lilley, Christina, Sadozye, Azmat, Maclean, Mary, Hall, Peter, Phillips, Angela, Greger, Alex, Madeleine, Jude, Petty, Russell D.

Volltext

Combining precision medicine and prophylaxis in oesophageal squamous cell carcinoma von Baxter, Mark A., Spender, Lindsay C., Petty, Russell D.

Volltext

Pembrolizumab versus paclitaxel in gastro-oesophageal adenocarcinoma von Smyth, Elizabeth C, Petty, Russell D

Volltext

Real-world challenge for clinicians treating advanced gastroesophageal adenocarcinoma (Review) von Baxter, Mark A., Petty, Russell D., Swinson, Daniel, Hall, Peter S., O'Hanlon, Shane

Volltext

APRIL is a novel clinical chemo-resistance biomarker in colorectal adenocarcinoma identified by gene expression profiling von Petty, Russell D, Samuel, Leslie M, Murray, Graeme I, MacDonald, Graham, O'Kelly, Terrence, Loudon, Malcolm, Binnie, Norman, Aly, Emad, McKinlay, Aileen, Wang, Weiguang, Gilbert, Fiona, Semple, Scot, Collie-Duguid, Elaina S R

Volltext

Immune checkpoint inhibition in advanced esophageal squamous cell carcinoma: how can we personalise management? von Cagney, Hannah P, Petty, Russell D, Baxter, Mark A

Volltext

Diagnosis, treatment, and outcome of patients with oesophagogastric cancer during the COVID-19 pandemic: national study von Baxter, Mark A, Khan, Khurram S, Gall, Lewis S, Samuelson, Catherine, McCollum, Catherine, Chuntamongkol, Rongkagorn, Narramneni, Lakshmi R, Al-Zuabi, Manaf, Bryce, Gavin, Shareef, Hala E J, Forshaw, Matthew, Petty, Russell D

Volltext

Novel biomarkers for risk stratification of Barrett’s oesophagus associated neoplastic progression–epithelial HMGB1 expression and stromal lymphocytic phenotype von Porter, Ross J., Murray, Graeme I., Brice, Daniel P., Petty, Russell D., McLean, Mairi H.

Volltext

Correction to: The impact of COVID-19 on systemic anticancer treatment delivery in Scotland von Baxter, Mark A., Murphy, John, Cameron, David, Jordan, Judith, Crearie, Christine, Lilley, Christina, Sadozye, Azmat, Maclean, Mary, Hall, Peter, Phillips, Angela, Greger, Alex, Madeleine, Jude, Petty, Russell D.

Volltext

Tumor Transcriptome Reveals the Predictive and Prognostic Impact of Lysosomal Protease Inhibitors in Non–Small-Cell Lung Cancer von PETTY, Russell D, KERR, Keith M, MURRAY, Graeme I, NICOLSON, Marianne C, ROONEY, Patrick H, BISSETT, Donald, COLLIE-DUGUID, Elaina S. R

Volltext

Multicentre validation of CT grey-level co-occurrence matrix features for overall survival in primary oesophageal adenocarcinoma von O’Shea, Robert, Withey, Samuel J., Owczarczyk, Kasia, Rookyard, Christopher, Gossage, James, Godfrey, Edmund, Jobling, Craig, Parsons, Simon L., Skipworth, Richard J. E., Goh, Vicky

Volltext

Exclusive rights in gastric cancer genomics von Petty, Russell D

Volltext

Interactions between anti-EGFR therapies and cytotoxic chemotherapy in oesophageal squamous cell carcinoma: why clinical trials might have failed and how they could succeed von Meemanage, Madusha, Spender, Lindsay C., Collinson, Diane, Iannetta, Joanna, Challapalli, Pranavi, Turbitt, Julie, Clark, Caroline, Baxter, Mark, Murray, Graeme, Walsh, Shaun, Miedzybrodzka, Zofia, Petty, Russell D.

Volltext

Female Sex but Not Oestrogen Receptor Expression Predicts Survival in Advanced Gastroesophageal Adenocarcinoma-A Post-hoc Analysis of the GO2 Trial von Baxter, Mark A, Spender, Lindsay C, Walsh, Shaun, Bray, Susan, Skinner, Gemma, King, Sharon, Hall, Peter S, Seymour, Matthew J, Petty, Russell D, On Behalf Of The Go Investigators

Volltext